Literature DB >> 1282702

Recognition of the high affinity binding site in rev-response element RNA by the human immunodeficiency virus type-1 rev protein.

S Iwai1, C Pritchard, D A Mann, J Karn, M J Gait.   

Abstract

The Human Immunodeficiency Virus type-1 rev protein binds with high affinity to a bubble structure located within the rev-response element (RRE) RNA in stemloop II. After this initial interaction, additional rev molecules bind to the RRE RNA in an ordered assembly process which requires a functional bubble structure, since mutations in the bubble sequence that reduce rev affinity block multiple complex formation. We have used synthetic chemistry to characterize the interaction between rev protein and its high affinity binding site. A minimal synthetic duplex RNA (RBC6) carrying the bubble and 12 flanking base pairs is able to bind rev with 1 to 1 stoichiometry and with high affinity. When the bubble structure is inserted into synthetic RNA molecules carrying longer stretches of flanking double-stranded RNA, rev forms additional complexes resembling the multimers observed with the RRE RNA. The ability of rev to bind to RBC6 analogues containing functional group modifications on base and sugar moieties of nucleoside residues was also examined. The results provide strong evidence that the bubble structure contains specific configurations of non-Watson--Crick G:G and G:A base pairs and suggest that high affinity recognition of RRE RNA by rev requires hydrogen bonding to functional groups in the major groove of a distorted RNA structure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282702      PMCID: PMC334559          DOI: 10.1093/nar/20.24.6465

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

1.  A specific sequence with a bulged guanosine residue(s) in a stem-bulge-stem structure of Rev-responsive element RNA is required for trans activation by human immunodeficiency virus type 1 Rev.

Authors:  S M Holland; M Chavez; S Gerstberger; S Venkatesan
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Use of synthetic oligoribonucleotides to probe RNA-protein interactions in the MS2 translational operator complex.

Authors:  S J Talbot; S Goodman; S R Bates; C W Fishwick; P G Stockley
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

3.  Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.

Authors:  L S Tiley; M H Malim; H K Tewary; P G Stockley; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

4.  Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein.

Authors:  E T Dayton; D A Konings; D M Powell; B A Shapiro; L Butini; J V Maizel; A I Dayton
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

5.  Rapid deprotection procedures for synthetic oligonucleotides.

Authors:  N N Polushin; I N Pashkova; V A Efimov
Journal:  Nucleic Acids Symp Ser       Date:  1991

6.  rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

Authors:  B K Felber; M Hadzopoulou-Cladaras; C Cladaras; T Copeland; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

7.  Synthesis of RNA containing inosine: analysis of the sequence requirements for the 5' splice site of the Tetrahymena group I intron.

Authors:  R Green; J W Szostak; S A Benner; A Rich; N Usman
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

8.  Conformation of the TAR RNA-arginine complex by NMR spectroscopy.

Authors:  J D Puglisi; R Tan; B J Calnan; A D Frankel; J R Williamson
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

9.  The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.

Authors:  D M D'Agostino; B K Felber; J E Harrison; G N Pavlakis
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs.

Authors:  S Heaphy; J T Finch; M J Gait; J Karn; M Singh
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

View more
  35 in total

1.  Polyvalent Rev decoys act as artificial Rev-responsive elements.

Authors:  T L Symensma; S Baskerville; A Yan; A D Ellington
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Crystal structures of two forms of a 14-mer RNA/DNA chimer duplex with double UU bulges: a novel intramolecular U*(A x U) base triple.

Authors:  J Deng; Y Xiong; C Sudarsanakumar; K Shi; M Sundaralingam
Journal:  RNA       Date:  2001-10       Impact factor: 4.942

3.  Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function.

Authors:  Deidra Shuck-Lee; Hua Chang; Emily A Sloan; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  In vitro and in vivo analysis of the interaction between RNA helicase A and HIV-1 RNA.

Authors:  Li Xing; Meijuan Niu; Lawrence Kleiman
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  Selective optimization of the Rev-binding element of HIV-1.

Authors:  L Giver; D Bartel; M Zapp; A Pawul; M Green; A D Ellington
Journal:  Nucleic Acids Res       Date:  1993-11-25       Impact factor: 16.971

Review 6.  Recent advances in RNA-protein interaction studies.

Authors:  K Nagai
Journal:  Mol Biol Rep       Date:  1993-08       Impact factor: 2.316

7.  Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway.

Authors:  R A Fridell; H P Bogerd; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

8.  Targeting nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection.

Authors:  R K Mishra; R Le Tinévez; J J Toulmé
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  The human endogenous retrovirus K Rev response element coincides with a predicted RNA folding region.

Authors:  J Yang; H Bogerd; S Y Le; B R Cullen
Journal:  RNA       Date:  2000-11       Impact factor: 4.942

10.  A solution to limited genomic capacity: using adaptable binding surfaces to assemble the functional HIV Rev oligomer on RNA.

Authors:  Matthew D Daugherty; Iván D'Orso; Alan D Frankel
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.